Taro Sakamoto

3.8k total citations · 2 hit papers
93 papers, 2.4k citations indexed

About

Taro Sakamoto is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Taro Sakamoto has authored 93 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 41 papers in Surgery and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Taro Sakamoto's work include Pancreatic and Hepatic Oncology Research (28 papers), Pancreatitis Pathology and Treatment (16 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). Taro Sakamoto is often cited by papers focused on Pancreatic and Hepatic Oncology Research (28 papers), Pancreatitis Pathology and Treatment (16 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). Taro Sakamoto collaborates with scholars based in Japan, United States and France. Taro Sakamoto's co-authors include Hirotaka Imai, Tomoko Koumura, Masaki Matsuoka, Takeshi Kumagai, Katsuhiko Yanaga, Hiroaki Shiba, Yasuhito Nakagawa, Takeshi Gocho, Koichiro Haruki and Yuki Fujiwara and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Taro Sakamoto

87 papers receiving 2.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis

2016 532 citations Taro Sakamoto et al. profile →
Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis

2019 399 citations Taro Sakamoto et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Taro Sakamoto	973	828	612	559	510	93	2.4k
Kunihiko Izuishi	528 0.5×	653 0.8×	368 0.6×	575 1.0×	927 1.8×	98	2.6k
Gregory Kouraklis	444 0.5×	1.2k 1.5×	463 0.8×	737 1.3×	859 1.7×	142	3.1k
Taku Naiki	545 0.6×	776 0.9×	278 0.5×	301 0.5×	599 1.2×	183	2.6k
Katsunori Furukawa	1.1k 1.1×	614 0.7×	291 0.5×	1.3k 2.4×	1.7k 3.3×	156	3.4k
Bostjan Humar	395 0.4×	1.3k 1.5×	433 0.7×	576 1.0×	972 1.9×	74	3.0k
Sandra Cerda	468 0.5×	649 0.8×	236 0.4×	716 1.3×	404 0.8×	72	2.2k
Jian Dong	306 0.3×	939 1.1×	527 0.9×	586 1.0×	454 0.9×	96	2.4k
Matthias Woenckhaus	337 0.3×	916 1.1×	221 0.4×	323 0.6×	336 0.7×	43	2.3k
Bin Yi	550 0.6×	1.9k 2.3×	1.0k 1.6×	740 1.3×	831 1.6×	151	3.6k
Chew-Wun Wu	541 0.6×	879 1.1×	494 0.8×	501 0.9×	736 1.4×	87	2.4k

Countries citing papers authored by Taro Sakamoto

Since Specialization

Citations

This map shows the geographic impact of Taro Sakamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taro Sakamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taro Sakamoto more than expected).

Fields of papers citing papers by Taro Sakamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taro Sakamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taro Sakamoto. The network helps show where Taro Sakamoto may publish in the future.

Co-authorship network of co-authors of Taro Sakamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Taro Sakamoto. A scholar is included among the top collaborators of Taro Sakamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taro Sakamoto. Taro Sakamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kowalski, William J., Taro Sakamoto, Wenling Li, et al.. (2025). In vivo transplantation of mammalian vascular organoids onto the chick chorioallantoic membrane reveals the formation of a hierarchical vascular network. Scientific Reports. 15(1). 7150–7150. 1 indexed citations

Tsunematsu, Masashi, Kenei Furukawa, Koichiro Haruki, et al.. (2024). The prognosis-based classification model in resectable pancreatic cancer. Surgical Oncology. 52. 102035–102035. 1 indexed citations

Tsunematsu, Masashi, Koichiro Haruki, Yoshihiro Shirai, et al.. (2024). The Signal Intensity Ratio of Pancreas to Spleen in Magnetic Resonance Imaging Can Predict Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy. Pancreas. 53(4). e310–e316.

Haruki, Koichiro, Mitsuru Yanagaki, Yoshihiro Shirai, et al.. (2024). The Significant Impact of Fibrinogen–C-Reactive Protein–Albumin Ratio on the Long-Term Outcomes After Pancreatic Resection for Pancreatic Cancer. Pancreas. 54(3). e194–e200.

Shirai, Yoshihiro, Shinji Onda, Ryoga Hamura, et al.. (2023). Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically resectable pancreatic cancer. Surgical Oncology. 51. 101998–101998. 1 indexed citations

Furukawa, Kenei, Tomohiko Taniai, Koichiro Haruki, et al.. (2023). Blood loss in laparoscopic distal pancreatectomy could be underestimated. Journal of Hepato-Biliary-Pancreatic Sciences. 30(7). 962–969. 2 indexed citations

Tsunematsu, Masashi, Takeshi Gocho, Mitsuru Yanagaki, et al.. (2022). The impact of postoperative exocrine index on non‐alcoholic fatty liver disease following pancreaticoduodenectomy. Annals of Gastroenterological Surgery. 6(5). 704–711. 6 indexed citations

Sakamoto, Taro, Masashi Tsunematsu, Yoshihiro Shirai, et al.. (2022). D1 Distal Pancreatectomy for Left-sided Pancreatic Ductal Adenocarcinoma Is Justifiable: A Propensity-score Matched Multicenter Study. Anticancer Research. 43(1). 201–208. 1 indexed citations

Matsumoto, Michinori, Katsuhiko Yanaga, Hiroaki Shiba, et al.. (2021). Treatment of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Annals of Gastroenterological Surgery. 5(4). 538–552. 9 indexed citations

10.

Taniai, Tomohiko, Shinji Onda, Shun Sato, et al.. (2020). Hepatic Epithelioid Hemangioendothelioma: Difficult Differential Diagnosis from Angiosarcoma. Case Reports in Gastroenterology. 14(1). 56–62. 5 indexed citations

11.

Taniai, Tomohiko, Koichiro Haruki, Michinori Matsumoto, et al.. (2019). Incidental abdominal lymph node metastases from a known breast cancer in resected specimen of invasive pancreatic ductal adenocarcinoma: report of a case. International Cancer Conference Journal. 8(4). 190–194.

12.

Tsunematsu, Masashi, Koichiro Haruki, Taro Sakamoto, et al.. (2019). Radical resection of an initially unresectable intrahepatic cholangiocarcinoma after chemotherapy with using gemcitabine, cisplatin, and S-1: report of a case. SHILAP Revista de lepidopterología. 5(1). 103–103. 1 indexed citations

13.

Fujiwara, Yuki, Ryoga Hamura, Koichiro Haruki, et al.. (2019). Combination of Distance from Superior Mesenteric Artery and Serum CA19-9 as a Novel Prediction of Local Recurrence in Patients With Pancreatic Cancer Following Resection. Anticancer Research. 39(3). 1469–1478. 6 indexed citations

14.

Shiba, Hiroaki, et al.. (2018). Repeated Clostridium difficile infection after living donor liver transplantation. Clinical Journal of Gastroenterology. 11(4). 309–311. 1 indexed citations

15.

Takenaka, Masataka, et al.. (2017). A Double-blind, Placebo-controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease. Journal of Veterinary Internal Medicine. 32(1). 236–248. 8 indexed citations

16.

Wakiyama, Shigeki, Michinori Matsumoto, Koichiro Haruki, et al.. (2017). Clinical Features and Outcome of Surgical Patients with Non-B Non-C Hepatocellular Carcinoma. Anticancer Research. 37(6). 3207–3213. 9 indexed citations

17.

Shiba, Hiroaki, Yuichi Ishida, Yuki Fujiwara, et al.. (2013). Practice to minimize the use of blood products improve outcome after hepatic resection for hepatocellular carcinoma.. PubMed. 60(127). 1681–3. 13 indexed citations

18.

Ishii, Yuji, Taro Sakamoto, Ryusuke Ito, & Katsuhiko Yanaga. (2009). F2-Isoprostanes and 2-Arachidonylglycerol as Biomarkers of Lipid Peroxidation in Pigs with Hepatic Ischemia/Reperfusion Injury. Journal of Surgical Research. 161(1). 139–145. 12 indexed citations

19.

Shiba, Hiroaki, Yuichi Ishida, Shigeki Wakiyama, et al.. (2008). Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinoma. Cancer Science. 99(10). 2104–2105. 19 indexed citations

20.

Ishii, Yuji, et al.. (2008). Anti-angiogenic Therapy on Hepatocellular Carcinoma Development and Progression. Journal of Surgical Research. 158(1). 69–76. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact